ArticleScientific reports2025
Novel Ni/Fe-MIL-53@ZnO nanocomposite for efficient photodegradation of aflatoxins G1 and G2.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The photodegradation of aflatoxins G1 and G2 (AFG1 and AFG2) is crucial for mitigating the health risks associated with these potent mycotoxins, as it enhances food safety and protects human health by reducing their persistence and bioavailability in contaminated environments. This study investigates the efficient photodegradation of AFG1 and AFG2 using a novel Bimetallic MIL-53 (Al, Ni)/ZnO nanoparticle composite as a photocatalyst. The catalyst was synthesized in two stages: Chemical synthesis of zinc oxide nanoparticles (ZnO NPs) and hydrothermal synthesis to form the composite. Optimization of a ZnO-based photocatalyst, synthesized by varying proportions of NiCl₂·6H₂O and Al(NO₃)₃·9H₂O, revealed that a 0.547 g:0.864 g ratio maximized photocatalytic degradation of AFG1 and AFG2. Through experimental design, the degradation process was optimized, identifying pH 4.1, 109 mg of photocatalyst, 35 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.